ctrl K

Tango Therapeutics Inc. (TNGX)

NASDAQ: TNGX · Real-Time Price · USD

1.36

-0.13 (-8.72%)

At close: Apr 29, 2025, 3:59 PM

1.42

4.41%

Pre-market: Apr 30, 2025, 08:08 AM EDT

Tango Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	42.07M	36.53M	24.86M	37.04M	7.66M	24.65M
Cost of Revenue	n/a	115.2M	4.03M	1.97M	1.63M	32.27M
Gross Profit	42.07M	-78.67M	20.83M	35.08M	6.03M	-7.63M
Operating Income	-145.59M	-114.17M	-111.07M	-58.19M	-52.2M	-15.16M
Interest Income	7.89M	6.62M	1.46M	495K	108K	684K
Pretax Income	-130.09M	-101.61M	-108.12M	-57.94M	-51.97M	-14.1M
Net Income	-130.3M	-101.74M	-108.18M	-58.23M	-51.86M	-14.1M
Selling & General & Admin	43.75M	35.5M	30.02M	17.6M	9.87M	7.54M
Research & Development	143.92M	115.2M	105.91M	77.64M	49.99M	32.27M
Other Expenses	n/a	n/a	2.95M	247K	120K	n/a
Operating Expenses	187.66M	150.7M	135.93M	95.23M	59.86M	7.15M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	187.66M	150.7M	135.93M	95.23M	59.86M	39.43M
Income Tax Expense	208K	134K	54K	292K	-108K	n/a
Shares Outstanding (Basic)	109.23M	94.57M	87.82M	62.11M	31.93M	8.99M
Shares Outstanding (Diluted)	109.23M	94.57M	87.82M	62.11M	31.93M	8.99M
EPS (Basic)	-1.19	-1.08	-1.23	-0.94	-1.62	-1.57
EPS (Diluted)	-1.19	-1.08	-1.23	-0.94	-1.62	-1.57
EBITDA	-145.59M	-111.76M	-109.46M	-57.29M	-51.48M	-14.52M
EBIT	-145.59M	-114.17M	-111.07M	-58.19M	-52.2M	-15.16M
Depreciation & Amortization	n/a	2.42M	4.03M	1.97M	1.63M	643K